Michael Henderson - Chief Executive Officer, Director at Apogee Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
APGE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Michael Henderson - trading volume in the past year for Apogee Therapeutics, Inc.

Holdings reported by Michael Henderson for Apogee Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.34M $80.3M $59.94 Nov 6, 2024 Direct
Stock Option (Right to Buy) 399K Dec 18, 2023 Direct Common Stock

Transactions reported by Michael Henderson for Apogee Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.